Spine VB Spine to Feature xvision X2 Headset and Vulcan Spinal System at NASS 2026 byJosh SandbergOctober 8, 2026
Financial Spine VB Spine Appoints Thomas E. Oglesby as New Chief Financial Officer byTim AllenOctober 6, 2026
Regulatory Spine Top Stories VB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression byJosh SandbergSeptember 29, 2026
Biologics Regulatory Spine VB Spine Receives FDA Clearances of Expanded Indications for Vitoss® Bone Graft Substitute and Interbody Cage Portfolio byTim AllenJuly 29, 2026
Spine VB Spine’s European Distribution Center Begins Shipping Orders Across Europe byJosh SandbergJuly 9, 2026
Spine VB Spine to Acquire CT-Fluoro Technology for Spine Applications from Augmedics byJosh SandbergJuly 7, 2026
Spine Top Stories VB Spine Funds Landmark Research to Deliver the First Predictive Blood Test for Scoliosis in Adolescents byTim AllenJune 5, 2026
Spine Top Stories VB Spine Completes Transaction of Augmented Reality Spine Platform from Augmedics byJosh SandbergApril 13, 2026
Spine Top Stories VB Spine Announces Successful First Clinical Cases of Vulcan™ Spinal System byTim AllenMarch 10, 2026
